HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethyl orthoformate → (E)-3-(4-chloro-3-trifluoromethyl-styryl)-1,2,4-oxadiazole
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethyl orthoformate | HCID 31214 | — |
| Reactant | (E)-4-chloro-3-trifluoromethyl-cinnamamide oxime | HCID 86748304 | — |
| Catalyst | Boron trifluoride etherate | HCID 8000 | — |
| Product | (E)-3-(4-chloro-3-trifluoromethyl-styryl)-1,2,4-oxadiazole | HCID 23364566 | 71% |
Reaction Steps
5.2 g (0.02 mol) of (E)-4-chloro-3-trifluoromethylcinnamamide oxime are initially introduced into 50 ml of triethyl orthoformate and 2 drops of boron trifluoride etherate are added at room temperature. The mixture is then stirred at reflux temperature for 2 hours and the whole batch is then concentrated in vacuo. The residue is then taken up in 100 ml of methylene chloride and washed consecutively with 100 ml of 2N hydrochloric acid, saturated sodium carbonate solution and water. The organic phase is dried over sodium sulphate and the solvent is subsequently distilled off. 3.9 g (71.0% of theory) of (E)-3-(4-chloro-3-trifluoromethyl-styryl)-1,2,4-oxadiazole are obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05428049 |
| Source dataset | uspto-grants-1995_06 |
| ORD ID | ord-6e2bde15ea614367b321bcbbc2e47f11 |
| Source note | uspto-grants-1995_06 |